Specialty Generics Target growth in extended release and niche generic products by leveraging Anchen's speed in submitting ANDAs with Paragraph IV certifications to capture first-to-market opportunities and compete effectively against larger peers.

US Market Focus Capitalize on a U.S. headquartered operation with a clear mission to deliver affordable generics to patients, positioning sales efforts around FDA-driven approvals, payer access, and distribution partnerships within the domestic market.

R&D-Powered Growth Emphasize partnerships that align with Anchen’s aggressive R&D to co-develop or accelerate generic launches, providing a pathway for expedited product timelines and extended product lifecycle management.

Integrated Capabilities Leverage Anchen’s fully integrated drug development, production, and sales infrastructure to offer end-to-end service packages—from formulation and manufacturing to regulatory support and market access strategies.

Talent & Culture Engage through collaboration with a team that values creativity, speed, and employee engagement, presenting opportunities for strategic programs, training, and knowledge sharing to sustain innovative execution.